BMC takes patent fight global
LAKE WALES, Fla. – BMC Medical and 3B Medical announced today that they have now filed challenges to ResMed patents in China, Germany and the United States. The move represents a “global strategy to go on (the) offense and seek to invalidate portions of ResMed’s patent portfolio” in all three countries, the company stated in a release. “We have to be proactive on the global landscape to assert our right to compete in this product space,” stated James Xu, president of BMC Medical, in the release. Additionally, BMC and 3B recently announced this month the formal filing of an Inter Partes Review (IPR) in the United States Patent and Trademark Office challenging the validity of a ResMed patent on a CPAP humidifier structure. “We are continuing to study ResMed’s patent portfolio to identify future challenges,” Xu stated. BMC and 3B are also awaiting the outcome of a trial before the International Trade Commission that was concluded in April. The trial was the result of a complaint filed by ResMed in July 2013 alleging infringement on several patents.